Pacific Biomarkers   Report issue

For profit Phase 3
Founded: Seattle WA United States (1989)

Organization Overview

First Clinical Trial
2009
NCT00982111
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now